ELLIPSE A/S: Financial statements 2013
CVR: 20560673
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ELLIPSE A/S (CVR 20560673) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 20,824,000 and a net result of DKK 4,548,000 compared with DKK 8,788,000 the year before. That is a decrease of 16.5% compared with the year before. Equity in the 2013 report amounted to DKK 29,538,000. The solvency ratio was 43.7%. The company had 30 employees in the financial year.
- Gross Profit
- DKK 20,824,000
- Profit/Loss
- DKK 4,548,000
- Equity
- DKK 29,538,000
- Total Assets
- DKK 67,564,000
- Employees
- 30
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 20.8 mio. | 4.5 mio. | 29.5 mio. | 30 |
| 2012 | - | 24.9 mio. | 8.8 mio. | 25 mio. | 28 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of July 1, 2013, John Goltermann Lassen has joined the board of directors of ELLIPSE A/S.
As of July 1, 2013, Bjørn Christ has joined the board of directors of ELLIPSE A/S.
As of July 1, 2013, Jacob Kildegaard Larsen has left the board of directors of ELLIPSE A/S.
ELLIPSE A/S has published its annual report for 2012. Gross profit came to DKK 24,935,000, and the net result was DKK 8,788,000.
As of February 28, 2013, John Mountjoy Arnberg is registered as vice chairman of ELLIPSE A/S.
About ELLIPSE A/S
ELLIPSE A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 1997. The company has been dissolved on 30 April 2025. The company was registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company was previously named 3D - DANISH DERMATOLOGIC DEVELOPMENT A/S. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK 1,300,672 and a net result of DKK -24,466,572 compared with DKK 1,121,861 the year before. Equity in the 2023 report amounted to DKK 40,227,789.